Key points are not available for this paper at this time.
This cohort study found that treatment duration among individuals starting methadone and buprenorphine-naloxone during 2020 to 2022 was lower than during 2014 to 2016. This study highlights the importance of ongoing evaluation of treatment effectiveness, given the dynamic nature of the opioid crisis. Further research is needed to improve treatment retention and improve the effectiveness of opioid use disorder treatment.
Kleinman et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: